Fulham Mariel, Power Michelle, Gray Rachael
Sydney School of Veterinary Science, Faculty of Science, The University of Sydney, Camperdown, NSW, Australia.
School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, North Ryde, NSW, Australia.
Front Microbiol. 2022 Dec 19;13:1048013. doi: 10.3389/fmicb.2022.1048013. eCollection 2022.
The gut microbiota is essential for the development and maintenance of the hosts' immune system. Disturbances to the gut microbiota in early life stages can result in long-lasting impacts on host health. This study aimed to determine if topical ivermectin treatment for endemic hookworm () infection in endangered Australian sea lion () pups resulted in gut microbial changes. The gut microbiota was characterised for untreated (control) ( = 23) and treated ( = 23) Australian sea lion pups sampled during the 2019 and 2020/21 breeding seasons at Seal Bay, Kangaroo Island. Samples were collected pre- and post-treatment on up to four occasions over a four-to-five-month period. The gut microbiota of untreated (control) and treated pups in both seasons was dominated by five bacterial phyla, , , and . A significant difference in alpha diversity between treatment groups was seen in pups sampled during the 2020/21 breeding season ( = 0.008), with higher richness and diversity in treated pups. Modelling the impact of individual pup identification (ID), capture, pup weight (kg), standard length (cm), age and sex on beta diversity revealed that pup ID accounted for most of the variation (35% in 2019 and 42% in 2020/21), with pup ID, capture, and age being the only significant contributors to microbial variation ( < 0.05). There were no statistically significant differences in the composition of the microbiota between treatment groups in both the 2019 and 2020/21 breeding seasons, indicating that topical ivermectin treatment did not alter the composition of the gut microbiota. To our knowledge, this is the first study to characterise the gut microbiota of free-ranging Australian pinniped pups, compare the composition across multiple time points, and to consider the impact of parasitic treatment on overall diversity and microbial composition of the gut microbiota. Importantly, the lack of compositional changes in the gut microbiota with treatment support the utility of topical ivermectin as a safe and minimally invasive management strategy to enhance pup survival in this endangered species.
肠道微生物群对于宿主免疫系统的发育和维持至关重要。生命早期阶段肠道微生物群的紊乱会对宿主健康产生持久影响。本研究旨在确定对濒危澳大利亚海狮幼崽的地方性钩虫感染进行伊维菌素局部治疗是否会导致肠道微生物变化。对2019年以及2020/21繁殖季节在袋鼠岛海豹湾采集的未经治疗(对照,n = 23)和经治疗(n = 23)的澳大利亚海狮幼崽的肠道微生物群进行了特征分析。在四到五个月的时间里,最多在四个时间点进行治疗前和治疗后的样本采集。两个繁殖季节中未经治疗(对照)和经治疗幼崽的肠道微生物群均由五个细菌门主导,即厚壁菌门、拟杆菌门、放线菌门、变形菌门和梭杆菌门。在2020/21繁殖季节采集的幼崽中,治疗组之间的α多样性存在显著差异(P = 0.008),经治疗的幼崽具有更高的丰富度和多样性。对个体幼崽标识(ID)、捕获、幼崽体重(kg)、标准体长(cm)、年龄和性别对β多样性的影响进行建模分析发现,幼崽ID占变异的大部分(2019年为35%,2020/21年为42%),幼崽ID、捕获和年龄是微生物变异的唯一显著贡献因素(P < 0.05)。在2019年和2020/21繁殖季节,治疗组之间微生物群的组成均无统计学显著差异,这表明伊维菌素局部治疗并未改变肠道微生物群的组成。据我们所知,这是第一项对自由放养的澳大利亚鳍足类幼崽的肠道微生物群进行特征分析、比较多个时间点的组成,并考虑寄生虫治疗对肠道微生物群总体多样性和微生物组成影响的研究。重要的是,治疗后肠道微生物群缺乏组成变化支持了伊维菌素局部治疗作为一种安全且微创的管理策略在提高该濒危物种幼崽存活率方面的效用。